Foundation Healthcare Holdings Limited (SGX:FHH)
Singapore · Delayed Price · Currency is SGD 0.7200
-0.0050 (-0.69%)
At close: Aug 28, 2026
SGX:FHH Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 252.98 | 231.23 | 198.92 | 112.41 |
Other Revenue | 0.14 | 0.14 | 0.25 | - |
| 253.12 | 231.38 | 199.17 | 112.41 | |
Revenue Growth | - | 16.17% | 77.18% | - |
Cost of Revenue | 136.47 | 119.39 | 101.8 | 52.8 |
Gross Profit | 116.65 | 111.98 | 97.37 | 59.61 |
Selling, General & Admin | 15.26 | 12.53 | 13.23 | 7.37 |
Amortization of Goodwill & Intangibles | 0.98 | 1.8 | 1.65 | 1.65 |
Other Operating Expenses | 13.71 | 11.82 | 10.69 | 6.74 |
Operating Expenses | 47.89 | 40.7 | 38.34 | 21.78 |
Operating Income | 68.76 | 71.28 | 59.02 | 37.83 |
Interest Expense | -18.46 | -17.82 | -17.43 | -10.73 |
Interest & Investment Income | 0.89 | 1.12 | 1.26 | 0.62 |
Other Non Operating Income (Expenses) | 0.95 | 0.58 | 0.7 | 0.24 |
EBT Excluding Unusual Items | 52.14 | 55.15 | 43.56 | 27.96 |
Merger & Restructuring Charges | -0.5 | -0.14 | -0.51 | -5.25 |
Impairment of Goodwill | - | - | - | -0.12 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.03 | -0 |
Asset Writedown | -0.01 | - | -0.12 | -0.81 |
Other Unusual Items | -2.51 | -2.84 | -0.09 | -7.5 |
Pretax Income | 49.12 | 52.16 | 42.87 | 14.28 |
Income Tax Expense | 11.34 | 10.94 | 9.69 | 6.95 |
Earnings From Continuing Operations | 37.78 | 41.22 | 33.19 | 7.33 |
Minority Interest in Earnings | -26.31 | -27.2 | -23.07 | -14.99 |
Net Income | 11.47 | 14.02 | 10.12 | -7.66 |
Net Income to Common | 11.47 | 14.02 | 10.12 | -7.66 |
Net Income Growth | - | 38.59% | - | - |
Shares Outstanding (Basic) | 660 | 660 | 660 | 648 |
Shares Outstanding (Diluted) | 660 | 660 | 660 | 648 |
Shares Change | - | - | 1.85% | - |
EPS (Basic) | 0.02 | 0.02 | 0.02 | -0.01 |
EPS (Diluted) | 0.02 | 0.02 | 0.02 | -0.01 |
EPS Growth | - | 38.95% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 64.05 | 68.04 | 67.28 | 28.28 |
Free Cash Flow Per Share | 0.10 | 0.10 | 0.10 | 0.04 |
Gross Margin | 46.09% | 48.40% | 48.89% | 53.03% |
Operating Margin | 27.17% | 30.81% | 29.64% | 33.65% |
Profit Margin | 4.53% | 6.06% | 5.08% | -6.81% |
Free Cash Flow Margin | 25.30% | 29.41% | 33.78% | 25.16% |
EBITDA | 73.54 | 73.29 | 60.9 | 38.66 |
EBITDA Margin | 29.05% | 31.68% | 30.58% | 34.39% |
D&A For EBITDA | 4.78 | 2.01 | 1.88 | 0.83 |
EBIT | 68.76 | 71.28 | 59.02 | 37.83 |
EBIT Margin | 27.17% | 30.81% | 29.64% | 33.65% |
Effective Tax Rate | 23.08% | 20.98% | 22.60% | 48.68% |